calendar

53 catalysts · 14 phase 2 completion · 9 phase 1 completion · 5 phase 2 initiation · 5 phase 0 trial completion · 5 filing · 4 phase 1 initiation

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

TA: cardiology×TA: ophthalmology×from 2017-02-10×clear all

type

phase 2 completion14
phase 1 completion9
phase 2 initiation5
phase 0 trial completion5
filing5
phase 1 initiation4

phase 1 2 completion4

phase 3 initiation3

phase iv trial initiation1

phase 2 results1

therapy area

Oncology148
Infectious Disease46
Cardiology37
Immunology35
Dermatology31
Pulmonology22
Women's Health19
Ophthalmology16
Pain15

Week of Apr 27, 2026

›Apr 30, 2026phase 2 completion103d agoNational Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)metformin hydrochloride ER

Therapy area: Cardiovascular, Genito Urinary System, Infectious Disease. Indication: Acute Renal Failure (ARF) (Acute Kidney Injury), Sepsis, Septic Shock

full page →metformin hydrochloride ER →source: globaldata

›Apr 30, 2026phase 2 completion103d agoCurtin University — influenza vaccine (Phase II Trial Completion)influenza vaccine

Therapy area: Cardiovascular. Indication: Myocardial Infarction

full page →influenza vaccine →source: globaldata

›Apr 30, 2026phase 2 completion103d agoDutch Heart Foundation — ghrelin (Phase II Trial Completion)ghrelin

Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Ischemic Stroke

full page →ghrelin →source: globaldata

← prev

page 2 of 2